Leukemia is a cancer of blood-forming tissues that disrupts normal blood cell production. It is classified by speed of progression (acute/chronic) and cell type (lymphocytic/myeloid), causing fatigue, bleeding, and infections.
Imatinib is a targeted cancer therapy that blocks specific molecular pathways driving tumor growth and proliferation.
Osimertinib is a targeted cancer therapy that blocks specific molecular pathways driving tumor growth and proliferation.
Ibrutinib is a targeted cancer therapy that blocks specific molecular pathways driving tumor growth and proliferation.
Sunitinib is a targeted cancer therapy that blocks specific molecular pathways driving tumor growth and proliferation.
Erlotinib is a targeted cancer therapy that blocks specific molecular pathways driving tumor growth and proliferation.
Gefitinib is a targeted cancer therapy that blocks specific molecular pathways driving tumor growth and proliferation.
Describe your symptoms and get a structured AI clinical assessment — possible causes, urgency level, and recommended next steps.
Start Free AI Analysis →Content on this page is informed by evidence-based clinical sources including: